Nanofat for the Face: Indications, Limits and Recovery
Nanofat is autologous fat that has been mechanically processed and filtered into a fine suspension for superficial application. Its purpose differs from conventional fat grafting: nanofat is not intended to create structural volume or lift descended tissue.
How nanofat differs from microfat
| Microfat | Nanofat | |
|---|---|---|
| Main purpose | Structural volume and contour | Selected superficial skin-quality indications |
| Particle profile | Small intact fat parcels | Finely processed suspension |
| Typical plane | Deeper, anatomy-dependent planes | Superficial or intradermal placement |
| Provides lift? | May support contour but does not replace lifting | No |
In periorbital treatment, microfat may be used in the tear trough, lid–cheek junction, temples and orbital contour. Nanofat may be placed more superficially when skin quality is part of the indication.
What may nanofat improve?
Nanofat has been studied for changes in skin quality, fine texture, superficial irregularities and selected pigmentation concerns. The scientific evidence is still evolving, and response varies. Claims of guaranteed “regeneration,” stem-cell replacement or complete correction of dark circles are not supported.
Dark circles may be pigmentary, vascular, structural or edema-related. Nanofat cannot treat every cause. Read Under-Eye Circles and Blepharoplasty for this distinction.
What nanofat cannot do
- Lift the brow, midface, jawline or neck
- Replace volume in the same way as microfat
- Remove excess eyelid skin
- Correct true eyelid ptosis
- Guarantee elimination of pigmentation or wrinkles
How it may be combined
Nanofat can be one component of an individualized plan that may also include Hybrid Blepharoplasty, microfat, video-assisted brow or midface surgery, laser or other dermatologic treatment. Combination is not obligatory; each step requires a specific anatomical indication.
Risks and recovery
Possible effects include swelling, bruising, tenderness, temporary redness, asymmetry, infection, irregularity and unpredictable degree of improvement. The donor area also has its own bruising, discomfort and contour risks.
Periorbital swelling may be more noticeable in patients with pre-existing malar edema, festoons or previous filler. When prior injectables are uncertain, dermatologic ultrasound can support planning.
When are results assessed?
Early swelling is not the result. Skin changes, when they occur, develop gradually and should be assessed over months. Some patients may obtain modest improvement; others may need complementary treatment or may not be appropriate candidates.
Questions for consultation
- Which specific skin finding are we treating?
- Do I need nanofat, microfat or neither?
- Could edema or previous filler limit the result?
- Would another dermatologic treatment be more suitable?
- What degree of improvement is realistic?
International patients should plan adequate time for assessment and early follow-up. Learn about Belvivere’s support for patients traveling to Brazil.
